Aethlon Medical Announces Pricing of $4.7 Million Public Offering

SAN DIEGO, May 15, 2024 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an aggregate of 8,100,000 shares of its…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks